This is module 1 of 4 focusing on the complexity of care for patients with relapsed/refractory ALL. Module 1 focuses on identifying a case where relapse has occurred. The overall series will identify patients who can benefit from CD22-directed ADC therapy, develop strategies to manage associated VOD, and collaborate across disciplines for patient-centered care.